You are here

Horizon Pharma

Roche, Horizon lead way for pharma reputation among rare disease patient groups

Roche, Horizon lead way for pharma reputation among rare disease patient groups

Medical Marketing and Media

Flag link:

Large pharmas probe takeover of Horizon Therapeutics

Large pharmas probe takeover of Horizon Therapeutics

BioPharma Dive

Flag link:

Horizon charts massive biologics expansion in Ireland, where it'll add 350 new jobs

Horizon charts massive biologics expansion in Ireland, where it'll add 350 new jobs

Fierce Pharma

drug manufacturing

Flag link:

In a quiet year for takeouts, who was buying?

In a quiet year for takeouts, who was buying?

EP Vantage

Jazz Pharmaceuticals

Flag link:

Horizon switched up strategy for Tepezza launch, moving quickly to DTC to reach eye disease patients

Horizon switched up strategy for Tepezza launch, moving quickly to DTC to reach eye disease patients

Fierce Pharma

thyroid eye disease

Flag link:

FDA in-house review spotlights an issue with one of Horizon's endpoints but notes efficacy for lead drug

FDA in-house review spotlights an issue with one of Horizon's endpoints but notes efficacy for lead drug

Endpoints

clinical trials

thyroid eye disease

Flag link:

Horizon Pharma’s Thyroid Eye Disease Treatment Could Become a Blockbuster, Analyst Predicts

Horizon Pharma’s Thyroid Eye Disease Treatment Could Become a Blockbuster, Analyst Predicts

BioSpace

thyroid eye disease

Flag link:

The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs

The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs

Yahoo/Benzinga

Concert Pharmaceuticals

Edwards Lifesciences

Precision Biosciences

Boston Scientific

Bristol-Myers Squibb

Seattle Genetics

Flag link:

After thyroid eye drug scores in PhIII test, Horizon Pharma readies marketing application

After thyroid eye drug scores in PhIII test, Horizon Pharma readies marketing application

Endpoints

thyroid eye disease

Flag link:

Genentech, Horizon Earn Spots on List of ‘Companies That Care’

Genentech, Horizon Earn Spots on List of ‘Companies That Care’

BioSpace

Flag link:

Horizon Pharma Receives Two Additional Patents on Ravicti

Horizon Pharma Receives Two Additional Patents on Ravicti

CP Wire

Flag link:

Horizon Pharma Receives Two Additional Patents on Ravicti

Flag link:

Physicians And Patients Finally Avoiding Horizon's Expensive, Low-Value Pain Drugs Duexis And Vimovo

Physicians And Patients Finally Avoiding Horizon's Expensive, Low-Value Pain Drugs Duexis And Vimovo

Forbes

Flag link:

Specialty pharmacy scrutiny hits again with state's focus on Horizon meds

Specialty pharmacy scrutiny hits again with state's focus on Horizon meds

Fierce Pharma

specialty pharmacies

Express Scripts

Valeant Pharmaceuticals

Flag link:

Krystexxa shows signs of life as Horizon keeps pushing sales force expansion

Krystexxa shows signs of life as Horizon keeps pushing sales force expansion

Fierce Pharma

Flag link:

Horizon CEO Tim Walbert knows patients because he is one

Horizon CEO Tim Walbert knows patients because he is one

Medical Marketing and Media

autoimmune disease

Flag link:

Horizon dives into eye treatments with River Visions acquisition

Horizon dives into eye treatments with River Visions acquisition

BioPharma Dive

Flag link:

Horizon Pharma buys River Vision and its fast-tracked eye med for $145M

Horizon Pharma buys River Vision and its fast-tracked eye med for $145M

Fierce Biotech

thyroid eye disease

Flag link:

Tapping into the rare disease market

Tapping into the rare disease market

BioPharma Dive

Flag link:

Horizon Pharma - Aggressive Acquirer Makes Another Move

Horizon Pharma - Aggressive Acquirer Makes Another Move

Seeking Alpha

Flag link:

Pages